Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 20, 2007

Entelos and Organon Renew Rheumatoid Arthritis Research Agreement

  • Entelos and Organon extended their ongoing rheumatoid arthritis collaboration.

    “Organon was one of the first companies to recognize the potential impact of Entelos’ biosimulation capability and therapeutic expertise,” states James Karis, president and CEO of Entelos. 

    In silico R&D is a predictive research method aimed at increasing efficiency and productivity across the entire drug discovery and development pipeline. Using virtual patients and virtual drugs and targets, experiments are simulated, rapidly testing what would otherwise take months or years to do in the laboratory or clinic.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »